Fulcrum Therapeutics, Inc.

Direct answer

Fulcrum Therapeutics, Inc. is publicly traded on NASDAQ under the ticker FULC.

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical firm committed to developing life-improving treatments for patients in the United States afflicted by genetically defined diseases with significant unmet medical needs. Its leading investigational therapies include losmapimod, a small molecule targeting facioscapulohumeral muscular dystrophy, and FTX-6058, an orally administered fetal hemoglobin...

Can you invest in Fulcrum Therapeutics, Inc.?

Yes. Fulcrum Therapeutics, Inc. trades publicly on NASDAQ as FULC.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Fulcrum Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.